- $7.12bn
- $6.18bn
- $937.46m
- 88
- 20
- 48
- 51
Annual balance sheet for Klaviyo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 328 | 386 | 739 | 881 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 6.29 | 10.7 | 23.1 | 43.1 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 356 | 428 | 803 | 980 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 89.7 | 91.5 | 80.4 | 91.1 |
| Other Long Term Assets | ||||
| Total Assets | 464 | 629 | 1,089 | 1,273 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 77 | 85 | 131 | 200 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 134 | 133 | 174 | 239 |
| Redeemable Preferred Stock | ||||
| Non Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 330 | 496 | 915 | 1,034 |
| Total Liabilities & Shareholders' Equity | 464 | 629 | 1,089 | 1,273 |
| Total Common Shares Outstanding |